Neben der bekanntesten sekundären Hyperpigmentierung, dem Melasma der Frauen bei hormoneller Umstellung, gibt es eine Vielzahl von weiteren Erkrankungen mit unterschiedlichen Pathomechanismen. Der folgende Beitrag gibt einen Überblick über die verschiedenen Bilder bis hin zur Sonderform der Ashy dermatosis sowie über mögliche therapeutische Ansätze.
Literatur
Gilchrest BA. Molecular aspects of tanning. J Invest Dermatol 2011; 131(E1): E14–7
Böhm M, Luger TA. α-Melanozyten-stimulierendes Hormon. Hautarzt 2010; 61: 497–504
Ke MS et al. Optimal treatments for hyperpigmentation. 9. J Cosmet Laser Ther. 2006; 8: 7–13
Lacz NL et al. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol 2004; 43: 362–5
Kang HY et al. Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. J Invest Dermatol. 2011; 131: 1692–700
Fistarol SK, Itin PH. Disorders of Pigmentation. J Dtsch Dermatol Ges 2010; 8: 187–201
Rigopoulos D et al. Hyperpigmentation and melasma. J Cosmet Dermatol 2007; 6: 195–202
Ramirez CO. Los Cenicientos (1957) Problema Clinico. In: Report of the First Central American Congress of Dermatology, San Salvador, December 5–8, 1957. San Salvador: Publisher, 1957: 122–130
Fernandez-Flores A, Montero MG. Ashy dermatosis, or „Tyndall-effect“ dermatosis. Dermatol Online J 2006; 12: 14
Ono S et al. Ashy dermatosis with prior pruritic and scaling skin lesions. J Dermatol 2012; Mar 28 (Epub ahead of print)
Vega-Memije ME, Domínguez-Soto L. Ashy dermatosis. Int J Dermatol 2010; 49: 228–9
Schwartz RA. Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis. Int J Dermatol. 2004; 43: 230–2
Vásquez-Ochoa LA et al. Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis). Int J Dermatol 2006;45: 937–4
Zaynoun S et al. Ashy dermatoses—a critical review of the literature and a proposed simplified clinical classification. Int J Dermatol. 2008}; 47: 542–4
Halder RM, Richards GM. Topical agents used in the management of hyperpigmentation. Skin Therapy Lett 2004; 9: 1–3
Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis 2006; 77: 45–50
Ke MS et al. Optimal treatments for hyperpigmentation. 9. J Cosmet Laser Ther. 2006; 8: 7–13
Ho SG et al. A retrospective analysis of the management of acne postinflammatory hyperpigmentation using topical treatment, laser treatment, or combination topical and laser treatments in oriental patients. Lasers Surg Med 2011; 43: 1–7
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krause, W. Krankheitsbild mit breitem Spektrum. ästhet dermatol kosmetol 6, 22–26 (2014). https://doi.org/10.1007/s12634-014-0917-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12634-014-0917-6